Early studies suggested that PPARγ may mediate cardioprotective effects on the vasculature.10 More recently, expression of dominant negative PPARγ isoforms in either endothelium or vascular smooth muscle caused an enhanced susceptibility to, or directly caused, vascular dysfunction and HTN.11–13. Here, PPARG is linked to hypertensive disorder.